CELCUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
CELCUITY INC. (CELC) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 65.00 million shares as of 2022-09-01, per its 10-K filed 2023-03-23.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2023-03-23
- 2022-09-01: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 65.00M shares.
- 2022-05-12: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 30.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2022-09-01 | 65.00M shares 10-K · filed 2023-03-23 |
| 2022-05-12 | 30.00M shares 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |